Correlation Between Day One and ImmunoGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and ImmunoGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and ImmunoGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and ImmunoGen, you can compare the effects of market volatilities on Day One and ImmunoGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of ImmunoGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and ImmunoGen.

Diversification Opportunities for Day One and ImmunoGen

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Day and ImmunoGen is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and ImmunoGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmunoGen and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with ImmunoGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmunoGen has no effect on the direction of Day One i.e., Day One and ImmunoGen go up and down completely randomly.

Pair Corralation between Day One and ImmunoGen

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the ImmunoGen. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 3.15 times less risky than ImmunoGen. The stock trades about -0.01 of its potential returns per unit of risk. The ImmunoGen is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  547.00  in ImmunoGen on August 23, 2024 and sell it today you would earn a total of  1,273  from holding ImmunoGen or generate 232.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy32.26%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  ImmunoGen

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
ImmunoGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmunoGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, ImmunoGen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Day One and ImmunoGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and ImmunoGen

The main advantage of trading using opposite Day One and ImmunoGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, ImmunoGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmunoGen will offset losses from the drop in ImmunoGen's long position.
The idea behind Day One Biopharmaceuticals and ImmunoGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges